[1]JournalofMedicinalChemistry,2000,vol.43,p.1234-1241
[2]Patent:WO2015/83033,2015,A1.Locationinpatent:Page/Pagecolumn11
[3]Patent:WO2010/18595,2010,A2.Locationinpatent:Page/Pagecolumn26
[4]Patent:US2011/130366,2011,A1.Locationinpatent:Page/Pagecolumn9
[5]Patent:WO2012/164576,2012,A2.Locationinpatent:Page/Pagecolumn6-7
[6]Patent:WO2017/93899,2017,A1.Locationinpatent:Page/Pagecolumn17;18
[1]JournalofMedicinalChemistry,2000,vol.43,p.1234-1241
[2]JournalofMedicinalChemistry,2000,vol.43,p.1234-1241
[3]Patent:US2011/130366,2011,A1
[1]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-WO2010/18595,2010,A2Locationinpatent:Page/Pagecolumn28-29
[2]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-US2011/130366,2011,A1Locationinpatent:Page/Pagecolumn10
[1]Locationinpatent:bodytextSkrdla,PeterJ.;Harrington.,Chandra;Lin.,Zhihao[InternationalJournalofChemicalKinetics,2010,vol.42,#1,p.25-36]
[1]CurrentPatentAssignee:Sandoz(in:Novartis);NOVARTISAG-WO2011/45817,2011,A2Locationinpatent:Page/Pagecolumn13
Title: Pranav Prasoon, et al. Role of fosaprepitant, a neurokinin Type 1 receptor antagonist, in morphine-induced antinociception in rats. Indian J Pharmacol. 2016 Jul-Aug; 48(4): 394-398.